MedTrace Logo

Treatment of Coronary In-Stent Restenosis

NCT01735825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2022-12-08

No results posted yet for this study

Summary

The purpose of this study is to compare efficacy of coronary in-stent restenosis therapy using drug eluting paclitaxel-coated balloon catheters with the latest generation of drug eluting stents releasing everolimus.

Conditions

  • Restenosis

Interventions

DEVICE

paclitaxel-coated balloon catheter with Iopromide coating

Patients with coronary in-stent restenosis treated by drug eluting paclitaxel-coated balloon catheter

DEVICE

drug eluting stent with everolimus

Patients with coronary in-stent restenosis treated by drug eluting stent with everolimus

DEVICE

seal-wing paclitaxel-eluting balloon catheter

Patients with coronary in-stent restenosis treated by seal-wing paclitaxel-eluting balloon catheter

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Leos Pleva, M.D. · Cardiovascular Department, University Hospital Ostrava, Czech Republic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2015-07-31
Completion
2018-06-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01735825 on ClinicalTrials.gov